U.S. Supreme Court
Apr. 1, 2011
High Court Hears Drug Labeling Case
In a sequal to a 2009 ruling on preemption with brand-name drug makers, the U.S. Supreme Court weighed Wednesday if federal labeling requirements shield generic drug manufacturers from state lawsuits.
Daily Journal Staff Writer
WASHINGTON - The U.S. Supreme Court weighed Wednesday whether federal labeling requirements shield generic drug manufacturers from state lawsuits claiming they failed to warn patients about the risks of their products.
The case is the sequel to a 2009 decision that found the Federal Food, Drug and Cosmetic Act did not pre-empt state failure-to-warn claims against makers of brand-name drugs. Wyet...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In